CYTOKINETICS INC ($CYTK)
Filing Information
| Accession Number | 0001061983-26-000015 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
78,000
Total Value
$2,388,060.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Common Stock | โ | Mar 5, 2026 | Exercise/Conversion | 11,000 | $39.13 | $430,430.00 | 76,440 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 5, 2026 | Sale | 15,000 | $61.87 | $928,050.00 | 61,440 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 5, 2026 | Sale | 11,000 | $61.88 | $680,680.00 | 50,440 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Mar 5, 2026 | Exercise/Conversion | 15,000 | $23.26 | $348,900.00 | 65,440 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Non-Qualified Stock Option (Right to Buy) | Derivative | Mar 5, 2026 | Exercise/Conversion | 11,000 | $0.00 | $0.00 | 24,403 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Non-Qualified Stock Option (Right to Buy) | Derivative | Mar 5, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 69,000 | Direct | โ | View Details |